Jane Street’s Axonics, Inc. Common Stock AXNX Stock Holding History

Jane Street’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,800	Closed	-$1.26M	–	10623
2024 Q2	$1.26M	Sell	18,800 -500	-3%	-$33.7K	﹤0.01%	5331
2024 Q1	$1.33M	Buy	19,300 +9,400	+95%	+$634K	﹤0.01%	4870
2023 Q4	$616K	Buy	+9,900	New	+$554K	﹤0.01%	6405
2022 Q3	–	Sell	-447,800	Closed	-$25.4M	–	10668
2022 Q2	$25.4M	Buy	447,800 +429,900	+2,402%	+$23.6M	0.01%	942
2022 Q1	$1.12M	Buy	17,900 +10,100	+129%	+$544K	﹤0.01%	5898
2021 Q4	$437K	Buy	7,800 +800	+11%	+$48.9K	﹤0.01%	7505
2021 Q3	$456K	Sell	7,000 -5,500	-44%	-$375K	﹤0.01%	7465
2021 Q2	$793K	Buy	12,500 +2,500	+25%	+$148K	﹤0.01%	6337
2021 Q1	$599K	Sell	10,000 -100	-1%	-$5.44K	﹤0.01%	6476
2020 Q4	$504K	Buy	10,100 +4,500	+80%	+$211K	﹤0.01%	5743
2020 Q3	$286K	Buy	+5,600	New	+$234K	﹤0.01%	5943

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's AXNX Position: Q4 2024 in Review

Jane Street sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 30,545 shares — an estimated $2.13M sold.

Jane Street first reported a position in AXNX in Q1 2020 and held it in 19 quarters. The position peaked at $3.82M in Q2 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Jane Street reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Jane Street sold 30,545 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.13M.
Jane Street first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 19 quarters.
Jane Street's Axonics, Inc. Common Stock position peaked at $3.82M in Q2 2022.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.